
Common oral anticoagulant rivaroxaban linked to highest risk of bleeding complications
A study compared the bleeding risks of the blood thinners rivaroxaban, apixaban, and warfarin for patients with blood clots or atrial fibrillation. Rivaroxaban was found to have a significantly higher risk of bleeding than apixaban and warfarin. The study involved over 10 years of patient data from Michigan’s Anticoagulation Quality Improvement Initiative registry. Researchers also…